Categories: Cantech Buzz

Against mounting evidence, Monsanto says its glyphosate-based weed-killers are safe

In 2007, Monsanto was convicted of false advertising in France after advertising Roundup as biodegradable and claiming that the product actually cleaned the soil after use. Monsanto is facing new allegations that its glyphosate-based weed killer, Roundup, is unsafe.

Monsanto today responded to a report from AP, who interviewed doctors in Argentina who said their caseloads revealed a correlation between industrial agriculture and rising cancer rates. Argentina’s agricultural production has tripled in the past two decades.

The company criticized the report as unscientific. Monsanto spokesperson Thomas Helscher said “the absence of reliable data makes it very difficult to establish trends in disease incidence and even more difficult to establish causal relationships. To our knowledge there are no established causal relationships.”

But AP says its story “cited hospital birth records, court records, peer-reviewed studies, continuing epidemiological surveys, pesticide industry and government data, and a comprehensive audit of agrochemical use in 2008-11 prepared by Argentina’s bipartisan Auditor General’s Office.”

This isn’t the first time Monsanto has faced challenges over the product. In 1996 it was forced to pull ads that claimed Roundup was “safer than table salt” and “practically nontoxic”.

In 2007, the St.Louis-based company was convicted of false advertising in France after advertising Roundup as biodegradable and claiming that the product actually cleaned the soil after use. The European Union declared has classified glyphosate as “dangerous for the environment” and “toxic for aquatic organisms”. Monsanto appealed this decision, but the verdict was upheld in the French Supreme Court in 2009.

On October 12th, more than 400 “Occupy Monsanto” rallies were held across the world, including several in Canada. Critics says Monsanto is the chief proponent of genetically modified plants they believe may be unsafe and should require more stringent labeling.

________

Staff

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

36 minutes ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

42 minutes ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

50 minutes ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

59 minutes ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

1 hour ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

1 hour ago